HCPCS code C1783 – Ocular implant

Key takeaways

HCPCS Code C1783 covers ocular implants that assist aqueous drainage, from micro-stents used in MIGS to traditional tube-shunt systems.

C1783 is billed in HOPD and ASC settings alongside a surgical CPT code. Payment is usually packaged within the APC for the glaucoma procedure.

Documentation must include the operative note, the implant sticker or manufacturer invoice, and a diagnosis that supports medically necessary glaucoma surgery.

Five pre-submission checks close the five denials that device-heavy ophthalmology claims attract most often.

Pabau’s claims management tools support accurate HCPCS Level II supply code entry, so ophthalmic billing teams see fewer denials on device cases.

HCPCS Code C1783: Definition and code attributes

HCPCS Code C1783 is an active HCPCS Level II supply code maintained by the Centers for Medicare and Medicaid Services (CMS). It describes an ocular implant that functions as an aqueous drainage assist device.

The code covers implantable devices placed surgically in the eye to create or enhance a drainage pathway for aqueous humor. That pathway lowers intraocular pressure (IOP) in patients with glaucoma. It sits within the C-series of HCPCS codes, reserved for outpatient facility device and supply reporting under the hospital Outpatient Prospective Payment System (OPPS).

The table below summarizes the key attributes of the code as they apply for the 2026 billing year.

Clinical context: Aqueous drainage devices and glaucoma

Aqueous drainage assist devices treat glaucoma by creating a controlled pathway through which aqueous humor exits the anterior chamber of the eye, reducing IOP. Chronically elevated IOP is the primary modifiable risk factor for glaucomatous optic nerve damage. When topical medications and laser treatments fail to reach target pressure, surgical implantation of a drainage device is indicated.

The device category covered by C1783 spans a range of implant designs. It runs from micro-scale stents used in minimally invasive glaucoma surgery (MIGS) to larger tube-shunt systems. Assigning the code to the wrong implant puts a high-cost device charge on the claim under the wrong descriptor, and payers catch that on review.

Common device categories that have been reported under C1783 include:

• MIGS stents (e.g. iStent inject by Glaukos): trabecular micro-bypass stents implanted ab interno through a small corneal incision, often combined with cataract surgery
• Suprachoroidal devices: implants that drain aqueous into the suprachoroidal space
• Subconjunctival gel stents (e.g. XEN Gel Stent by Allergan): micro-stents creating a bleb-forming subconjunctival drainage pathway
• Traditional tube-shunt systems (e.g. Ahmed Glaucoma Valve by New World Medical): plate-based devices for refractory glaucoma cases

Note: the Alcon CyPass Micro-Stent was withdrawn from the market in 2018 and is no longer a billable device. Coders should verify each device’s current FDA-approval status before assigning C1783.

Where C1783 is billed: Settings and APC packaging

HCPCS Code C1783 applies exclusively in outpatient facility settings. Physician offices and inpatient hospital stays do not use C-series supply codes, and those settings bill devices through different mechanisms. The two applicable settings carry different payment structures under Medicare.

Under the OPPS, CMS assigns most C-series device codes to an APC group tied to the primary surgical procedure. In practice, the facility fee for the glaucoma surgery already includes an assumption of device cost.

Whether C1783 receives separate payment or is fully packaged can shift year to year as CMS recalibrates APC weights. Coders should pull the current year’s OPPS Addendum B and confirm the active payment indicator before billing.

Medicare reimbursement and the 2026 fee schedule

Medicare payment for HCPCS Code C1783 under the OPPS is tied to the APC assigned to the surgical procedure. There is no standalone device fee schedule rate. Because aqueous drainage device costs are usually packaged into the procedure APC, facilities do not always receive a discrete line-item payment for the device.

For ASC settings, CMS maintains a separate ASC payment system with its own payment indicators. Some device-intensive glaucoma procedures carry a device-offset payment or a separately payable status for the device. The specific payment indicator for C1783 in ASC settings can be confirmed in the annual CMS ASC Addendum AA and Addendum BB files.

Key reimbursement principles to apply when billing C1783:

• APC packaging: check the current OPPS Addendum B before finalizing the claim. It shows whether C1783 is packaged (status indicator N or Q) or separately payable (status indicator K)
• Device offset: in ASC settings, some MIGS procedures carry a device-offset payment that partially reimburses the implant cost. Check the ASC payment indicators for the companion CPT code
• National vs. local amounts: Medicare OPPS payment amounts are national, while commercial payer rates are negotiated separately and vary widely
• Beneficiary cost-sharing: the standard 20% Medicare Part B coinsurance applies to separately payable HOPD device charges; check plan design for ASC cases

For current 2026 payment figures, reference the official CMS OPPS Addendum B directly. Published third-party rates can lag behind mid-year CMS corrections. Remittance advice on paid and adjusted C1783 claims gives billing teams a practical benchmark for what each payer actually pays.

C1783 billing guidelines and documentation requirements

Correct billing for HCPCS Code C1783 rests on three checks. Pair it with the right surgical CPT code, report accurate units, and supply documentation that proves both medical necessity and device identity. Missing any one of them is the most common reason a C1783 claim is denied or returned to the provider.

Units and modifiers

Report one unit of C1783 per device implanted. For bilateral glaucoma surgery in the same operative session, report two units with the appropriate modifier to distinguish eyes. Some payers prefer two separate line items instead. Verify bilateral rules against current National Correct Coding Initiative (NCCI) edits before submitting, since bundling edits between C1783 and companion CPT codes can apply.

Required documentation

• Operative report: it must name the specific device implanted and describe the surgical approach, whether ab interno, ab externo, or combined with phacoemulsification. It also confirms the indication that links to the ICD-10-CM diagnosis code on the claim
• Implant sticker or manufacturer invoice: the device label carries the lot number and the catalog number. It proves the implant named in the operative report was the one used, and that it matches the billed HCPCS code
• IOP documentation: pre-operative IOP readings, medication failure history, or prior laser treatment records support medical necessity. Many payers require evidence that less invasive treatments were attempted first
• Prior authorization documentation: if the payer required prior auth, attach the approval number, because claims submitted without auth when required are denied on first pass

The diagnosis on the claim has to carry the same specificity as the chart. Where the operative note records glaucoma without naming a type, the claim falls back to H40.9. Many payers read that as thin support for a drainage implant.

Each item on that list closes a specific denial. The pairing below maps the five pre-submission checks against the five rejections C1783 claims attract most often.

Flag missing sticker documentation before the claim leaves the billing department. That one check heads off most of the denial codes that device claims attract. For a MIGS case, that means the operative note, the device label, and the diagnosis codes. All three carry the same date of service on one UB-04 transaction.

Common denial reasons

• Missing or unattached implant sticker or invoice
• Diagnosis code does not support medical necessity for a drainage implant, such as ocular hypertension reported without confirmed glaucoma
• Bundling conflict between C1783 and the companion CPT code under NCCI edits
• Prior authorization not obtained, or obtained but not attached to the claim
• Incorrect setting — C1783 submitted on a physician office claim form (CMS-1500) rather than a facility claim (UB-04)

Device claims also need a current mapping of which implant each manufacturer assigns to which HCPCS code. Manufacturers update their reimbursement guides when CMS issues a new code or reclassifies an existing one. A mapping built two years ago will be out of date.

Related CPT and HCPCS codes used with C1783

HCPCS Code C1783 is never billed in isolation. It always accompanies a surgical CPT code that describes the operative procedure. The CPT code drives the APC assignment and the bulk of the facility payment, while C1783 reports the device itself. The codes below are the ones commonly paired with C1783 in glaucoma surgery billing.

Verify that the CPT-to-C1783 pairing you are billing does not trigger an NCCI edit before submission. The AAPC Codify HCPCS code lookup tool includes crosswalk data and edit indicators that help coders confirm valid code combinations.

Payer coverage policies

Medicare covers aqueous drainage devices as part of medically necessary glaucoma surgery when IOP cannot be controlled by medications or laser treatment. Coverage is governed nationally by Medicare’s OPPS packaging rules. Locally, it follows the Local Coverage Determinations (LCDs) for glaucoma surgery issued by Medicare Administrative Contractors (MACs).

Commercial payer coverage for HCPCS Code C1783 varies widely across plans. The variables that decide it are:

• Prior authorization: many commercial payers require prior authorization for MIGS procedures and the associated device. The request usually has to specify the device by name and catalog number
• Step therapy requirements: some payers require documented failure of two or more topical medications before approving a drainage implant
• Device-specific coverage: not every aqueous drainage device is covered equally. Check the payer’s current procedure-specific policy rather than assuming one implant stands in for another
• Investigational classification: some payers classify newer MIGS devices as investigational even after FDA clearance. Obtain written coverage confirmation before scheduling the case

Build a payer-by-payer coverage matrix for the glaucoma implants your surgeons use most often. It prevents last-minute auth failures and lets the scheduling team flag cases that need extra lead time. The NLM HCPCS Level II API gives programmatic access to code descriptions, which helps when that matrix is built as an internal tool.

Code history and effective dates

C1783 is an established HCPCS Level II code that has stayed active across multiple coding years. Aqueous drainage devices remain in sustained clinical use in glaucoma surgery. CMS reviews C-series device codes annually as part of the OPPS rulemaking cycle. That review can change APC assignment and packaging status without changing the code descriptor.

Device-category codes like C1783 are occasionally supplemented when CMS decides a novel device type warrants its own descriptor. The annual CMS HCPCS update files are the reliable place to catch those additions before they reach a claim.

How practice management software supports C1783 billing

HCPCS Code C1783 sits where clinical documentation, device tracking, and claims accuracy meet. Manual handoffs between those three create most of the risk on a glaucoma device claim. The implant label lives in the operating room, and the claim is built somewhere else.

Practice management software like Pabau closes that distance. Pabau’s claims management software supports HCPCS Level II supply code entry alongside CPT procedure codes. Billing staff can build glaucoma surgery claim templates that pull C1783 automatically when the surgical CPT code is selected. The device line stops depending on someone remembering to add it.

Capturing device identity on the superbill at the point of service means the label data is already on file when the claim is built. Denials that trace back to missing device documentation stop reaching the payer at all.

Some practices run multiple surgeons across several procedure locations. A centralized system that flags missing implant stickers before submission closes the most common denial pathway on C1783 cases. No separate billing QA step is needed for every encounter.

Reduce denials on device-intensive claims

Pabau’s claims management tools link HCPCS supply codes to surgical CPT codes for ophthalmic billing teams. They also flag missing documentation before submission and track remittance on device cases.

Book a demo

Conclusion

The work that decides whether a C1783 claim gets paid happens before anyone submits it. APC packaging status, NCCI edits, prior authorization, and device-specific coverage policies all land on the same glaucoma claim. Every one of them can be checked in advance.

Run the five checks above on every device case, and reconcile the status indicator each October when the new OPPS payment year starts. The trade-off is a few minutes per case against a denial that takes weeks to work back through appeals.

Pabau’s claims management tools pair C1783 with the right surgical CPT code and flag missing device documentation before the claim goes out. Book a demo to see how supply code billing works for an ophthalmology practice in Pabau.

Continue your research

Need to understand how claim denials are categorized? Denial codes in medical billing breaks down the CARC and RARC codes that turn up on remittances for device-intensive surgical claims.

New to facility billing workflows? What is medical billing covers the steps from encounter to payment that every supply code sits inside.

Want fewer first-pass rejections on surgical claims? Clean claim submission sets out what a payer needs on the first attempt, including the attachments device claims require.

Already working a backlog of denied device claims? Denial management in healthcare explains how to triage rejections by root cause instead of by date received.

Reconciling what Medicare actually paid? Electronic remittance advice shows how to read an ERA and spot underpayments on packaged device lines.

Frequently asked questions